Biotech

All Articles

IN 8bio standstills period 2 test, lays off half of staff

.Just a few months after dosing the initial person in a stage 2 test for newly detected glioblastoma...

Lilly, Haya ink $1B biobuck being overweight pact to look darker genome

.Eli Lilly's look for obesity intendeds has led it to the black genome. The Big Pharma has actually ...

ArsenalBio elevates $325M, turns out of previous lead possession

.Collection Biosciences is actually going on up. The tissue therapy firm has added $325 thousand in ...

Lilly- backed weight-loss biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to de...

Aelis' cannabis make use of medicine fails stage 2b, driving Indivior to reassess $100M option

.Aelis Farma's hopes of protecting a quick, beneficial choice on a $one hundred million choice settl...

ProKidney halts phase 3 test not required for cell therapy confirmation

.ProKidney has actually quit among a pair of period 3 trials for its own cell treatment for renal il...

Vaxcyte rises on 'spectacular' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what analysts called "spectacular" phase 1/2 records for its own 31-valent pneumoc...

Recursion's mind disease trial presents scant documentation of efficacy

.Recursion has actually discovered through a very early exam of its own tech-enabled method to medic...

Acepodia, Pfizer click on with each other for chemistry-based cell treatment

.Contact it a situation of great chemistry: Acepodia, a biotech based on Nobel Prize-winning scienti...

Praxis epilepsy medication reduces seizures in period 2 trial

.Praxis Precision Medicines has racked up an additional midphase win in epilepsy this year, with its...